Submitted cover letter and resume then heard back within a few days about interview. First round Interview was only 30minutes and consisted of about 5-10 minutes of fit/behavioral questions, 15-20 minutes of a case, and 3-5 minutes of questions for the interviewer. The case wasn't too difficult and the interview was more of a discussion. It dealt with moving forward with a new treatment for a rare disease. Heard back the following day about final round interview in their office. The final round interview started with a lunch with current analysts and then a mini-presentation on the firm. Everyone was nice. Following this, there were four interviews with two analysts, an engagement manager, and a principal. Each were about 30-45 min with fit, case, and time for questions. The senior members' were definitely more difficult (one number heavy and one more conceptual). Talking with everyone was enjoyable and they all loved the firm. Received a call with an offer about an hour and a half after leaving the interview.
I applied online. I interviewed at ClearView Healthcare Partners (New York, NY)
Interview
1 behavioral and 1 case study interview. Behavioral were common questinos: Why consulting, why Clearview, intro, a time you problem-solved, a time you worked with a difficult person. The case study was rushed, and it felt like someone was breathing down my neck. Market sizing and suggestions as to what actions the client should take.
Heard back the day after the deadline to schedule first round interview. 1 behavioral and 1 case. Then heard back within 2 days to schedule the final round which consisted of a strategy case and scientific discussion. Heard back within 2 days that I didn’t get the position. Quick response times and friendly people.
First round was a case interview with a consultant directly followed by a behavioral interview with HR. Behavioral questions were typical ones like "tell me about a time you made mistakes." Overall very respectful and pleasant conversation.
Interview questions [1]
Question 1
should client aquire a biotech company with drug A